DE3782430T2 - Verwendung eines trypsininhibitors des kunitztyps aus sojabohnen und seiner derivate zur herstellung von medikamenten und denselben enthaltendes agens. - Google Patents

Verwendung eines trypsininhibitors des kunitztyps aus sojabohnen und seiner derivate zur herstellung von medikamenten und denselben enthaltendes agens.

Info

Publication number
DE3782430T2
DE3782430T2 DE8787111047T DE3782430T DE3782430T2 DE 3782430 T2 DE3782430 T2 DE 3782430T2 DE 8787111047 T DE8787111047 T DE 8787111047T DE 3782430 T DE3782430 T DE 3782430T DE 3782430 T2 DE3782430 T2 DE 3782430T2
Authority
DE
Germany
Prior art keywords
soybeans
medicines
derivatives
production
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787111047T
Other languages
English (en)
Other versions
DE3782430D1 (de
Inventor
Hiroshi Maeda
Yasuhiro Matsumura
Kiyoharu Takamatsu
Tadahisa Shimoda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuji Oil Co Ltd
Original Assignee
Fuji Oil Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Oil Co Ltd filed Critical Fuji Oil Co Ltd
Application granted granted Critical
Publication of DE3782430D1 publication Critical patent/DE3782430D1/de
Publication of DE3782430T2 publication Critical patent/DE3782430T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
DE8787111047T 1986-01-31 1987-07-30 Verwendung eines trypsininhibitors des kunitztyps aus sojabohnen und seiner derivate zur herstellung von medikamenten und denselben enthaltendes agens. Expired - Fee Related DE3782430T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP61020362A JPH0623113B2 (ja) 1986-01-31 1986-01-31 癌性胸・腹水貯留抑制剤
EP87111047A EP0301122B1 (de) 1986-01-31 1987-07-30 Verwendung eines Trypsininhibitors des Kunitztyps aus Sojabohnen und seiner Derivate zur Herstellung von Medikamenten und denselben enthaltendes Agens

Publications (2)

Publication Number Publication Date
DE3782430D1 DE3782430D1 (de) 1992-12-03
DE3782430T2 true DE3782430T2 (de) 1993-04-15

Family

ID=12024979

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787111047T Expired - Fee Related DE3782430T2 (de) 1986-01-31 1987-07-30 Verwendung eines trypsininhibitors des kunitztyps aus sojabohnen und seiner derivate zur herstellung von medikamenten und denselben enthaltendes agens.

Country Status (3)

Country Link
EP (1) EP0301122B1 (de)
JP (1) JPH0623113B2 (de)
DE (1) DE3782430T2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2246779B (en) * 1990-08-03 1994-08-17 Delta Biotechnology Ltd Tumour-associated protease inhibitors targeted to tumour cells
ES2375703T3 (es) * 1999-11-05 2012-03-05 Johnson & Johnson Consumer Companies, Inc. Composiciones despigmentantes a base de soja para el cuidado de la piel.
US7309688B2 (en) * 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
FI20020332A0 (fi) * 2002-02-20 2002-02-20 Heino Pekka Untamo Valmiste ja menetelmä painon pudottamiseksi
DK1941867T3 (da) 2002-06-07 2012-01-02 Dyax Corp Polypeptid med modificeret Kunitz domæne
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
WO2005021557A2 (en) 2003-08-29 2005-03-10 Dyax Corp. Poly-pegylated protease inhibitors
EP1731160B1 (de) * 2004-02-27 2012-07-11 Fuji Oil Company, Ltd. Zusammensetzung zur hemmung von krebsmetastasen
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
CA3168591A1 (en) 2010-01-06 2011-07-14 Takeda Pharmaceutical Company Limited Plasma kallikrein binding proteins
KR102502293B1 (ko) 2011-01-06 2023-02-21 다케다 파머수티컬 컴패니 리미티드 혈장 칼리크레인 결합 단백질
NZ744233A (en) 2015-12-11 2023-11-24 Takeda Pharmaceuticals Co Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853708A (en) * 1970-01-23 1974-12-10 Exploaterings Ab Tbf Coupling biologically active substances to oxirane-containing polymers

Also Published As

Publication number Publication date
JPH0623113B2 (ja) 1994-03-30
JPS62294622A (ja) 1987-12-22
EP0301122A1 (de) 1989-02-01
EP0301122B1 (de) 1992-10-28
DE3782430D1 (de) 1992-12-03

Similar Documents

Publication Publication Date Title
DE69203958T2 (de) Produktionssystem zur Herstellung von Kleidung und anderen Produkten.
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
DE69212620T2 (de) Verwendung von Glycosaminoglycanen zur Behandlung von diabetischer Nephropathie und diabetischer Neuropathie
ATE188965T1 (de) Neue pyrazincarboxamidderivate, ihre herstellung und ihre verwendung in arzneimitteln
DE3782430T2 (de) Verwendung eines trypsininhibitors des kunitztyps aus sojabohnen und seiner derivate zur herstellung von medikamenten und denselben enthaltendes agens.
DE69512233D1 (de) Eine fertigungsstrasse zur herstellung von absorbierenden wegwerfartikeln
DE3483279D1 (de) Verwendung einer sekretolytisch wirkenden substanz zur herstellung eines antischnarchmittels und zur bekaempfung des schnarchphaenomens.
DE69223011T2 (de) Verfahren zur Herstellung von Alkoholen und Ketonen
DE59003534D1 (de) Verfahren zur Herstellung von Triethylendiamin und Piperazin.
DE3885818D1 (de) Trinatriumsalz des 2,4,6-Trimercapto-s-triazin-nonahydrats und Verfahren zur Herstellung.
DE59408857D1 (de) Vorrichtung zur kontinuierlichen Herstellung von Polyacetalen und ihre Verwendung
DE69005978D1 (de) Verwendung von Actinonin zur Herstellung eines Medikamentes zur Inhibierung der Angiogenese.
DE69205535T2 (de) Verfahren zur Herstellung von Phenylbutyronitrilen und Verwendung in der Parfümerie des 2,2-Dimethyl-4-Phenyl-Valeriannitrile.
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
DE3586420D1 (de) Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose.
DE69300037T2 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
DE69030012D1 (de) Photohärtbare Zusammensetzungen und ihre Verwendung zur Herstellung von Bildern
DE68908404T2 (de) Lang haltende zusammensetzung von propafenon und chinidin zur behandlung des zustandes des herzens.
DE59003312D1 (de) Verwendung von Diphenyletherderivaten zur Desikkation und Abszission von Pflanzenorganen.
DE59005925D1 (de) Verfahren zur Herstellung und Reinigung von 2-Hydroxy-4-(2'-hydroxy-ethoxy)-phenylarylketonen.
DE69220448D1 (de) Verfahren zur Herstellung von Cumarin und Derivaten davon
DE68920493T2 (de) Verfahren zur Herstellung von Derivaten von 2'-Deoxy-beta-cytidin und Salze davon.
ATA180891A (de) Verwendung von avena sativa l. zur herstellung von arzneimitteln
DE69402241T2 (de) Verwendung von 2-Acetylpyridine zur Herstellung eines Arzneimittles zur Unterdrückung des Rauchens
DE59208376D1 (de) Verfahren zur Herstellung von oligomeren Polyisocyanaten und ihre Verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee